Ciprofloxacin

CAS No. 85721-33-1

Ciprofloxacin ( Ciprofloxacin; Baflox; Cetraxal; Ciprolin; Fimoflox; Proflaxin; Spitacin )

Catalog No. M16218 CAS No. 85721-33-1

Ciprofloxacin is a broad-spectrum antimicrobial carboxyfluoroquinoline.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 37 In Stock
1G 53 In Stock

Biological Information

  • Product Name
    Ciprofloxacin
  • Note
    Research use only, not for human use.
  • Brief Description
    Ciprofloxacin is a broad-spectrum antimicrobial carboxyfluoroquinoline.
  • Description
    Ciprofloxacin is a broad-spectrum antimicrobial carboxyfluoroquinoline.
  • Synonyms
    Ciprofloxacin; Baflox; Cetraxal; Ciprolin; Fimoflox; Proflaxin; Spitacin
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Topoisomerase
  • Recptor
    Topo II; Topo IV
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    85721-33-1
  • Formula Weight
    331.34
  • Molecular Formula
    C17H18FN3O3
  • Purity
    >98%(HPLC)
  • Solubility
    Ethanol: <1 mg/mL (<1 mM); Water: <1 mg/mL (<1 mM); DMSO: <1 mg/mL (<1 mM)
  • SMILES
    OC(C1=CN(c2c(C1=O)cc(F)c(N3CCNCC3)c2)C4CC4)=O
  • Chemical Name
    1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wise R, et al. Antimicrob Agents ChemOthers, 1983, 23(4), 559-564.
molnova catalog
related products
  • Idarubicin hydrochlo...

    An anthracycline antileukemic that inserts into DNA and prevents DNA unwinding by interfering with the enzyme Topoisomerase II in cancer cells.

  • Cinoxacin

    Cinoxacin was an older synthetic antimicrobial related to the quinolone class of antibiotics with activity similar to oxolinic acid and nalidixic acid.

  • N-Acetyl-D-Glucosami...

    N-acetyl-D-Glucosamine (GlcNAc) is a monosaccharide derivative of glucose. It is released by the action of O-GlcNAcase, in mammalian systems from proteins that have been post-translationally modified with O-GlcNAc.